[Extrapyramidal complications during treatment with chlorpromazine and reserpine: clinical and electromyographic study].
作者信息
Delay J, Deniker P, Bourguignon A, Lempérière T
出版信息
Vertex. 2005 Nov-Dec;16(64):469-72.
PMID:16314902
Abstract
摘要
相似文献
1
2
3
[Neuroleptics and the extrapyramidal system].[抗精神病药物与锥体外系]
Arzneimittelforschung. 1978;28(9):1536-7.
4
[Extrapyramidal movement disorders arising during treatment of psychoses with drugs].[使用药物治疗精神病期间出现的锥体外系运动障碍]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1976;76(3):453-7.
5
The extrapyramidal neuroleptic syndrome: description and measurement.锥体外系神经阻滞剂综合征：描述与测量
Curr Ther Res Clin Exp. 1973 Jul;15(7):427-40.
6
A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.有或无锥体外系运动症状患者中抗精神病药物限定日剂量与氯丙嗪等效剂量的比较。
J Clin Psychopharmacol. 2010 Dec;30(6):741-3. doi: 10.1097/JCP.0b013e3181fab7ca.
7
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Encephale. 1956;45(4):1083-9.
8
Extrapyramidal side effects: a historical perspective.锥体外系副作用：历史视角
J Clin Psychiatry. 1987 Sep;48 Suppl:3-6.
9
Neuroleptic-associated catatonic reaction.抗精神病药物相关的紧张症反应。
Clin Pharm. 1983 Nov-Dec;2(6):581-2.
10
Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
Clin Neuropharmacol. 1983;6 Suppl 1:S9-26.
Zotero 插件